Very nice.
NEW YORK: Enriching T cells — a type of white blood cell — to attack certain cancerous diseases may prove beneficial to an increasing number of children during immunotherapy, says a study.
Younger T cells, classified as either naive T cells (newly minted cells) or stem central memory T cells (self-renewing, highly proliferative cells) were the most effective in immunotherapy, the study showed.
“Our main finding is that younger T cells are critically important in T cell immunotherapy,” said David M. Barrett, paediatric oncologist at The Children’s Hospital of Philadelphia (CHOP), University of Pennsylvania, US.
Comments are closed.